Pale Fire Capital SE »

Syros Pharmaceuticals shares owned by Pale Fire Capital SE

Quarter-by-quarter ownership of Syros Pharmaceuticals (SYRS) shares owned by Pale Fire Capital SE from 13F filings

Historical chart of Pale Fire Capital SE investment in Syros Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syros Pharmaceuticals held by Pale Fire Capital SE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syros Pharmaceuticals by Pale Fire Capital SE

Quarter filed Position value Share count Share price at filing
2024-09-30 $106k 49k 2.15

More positions owned by Pale Fire Capital SE

At&t (T)
Dole Ord Shs (DOLE)
Groupon Com New (GRPN)
B2gold Corp (BTG)
International Seaways (INSW)
Teladoc (TDOC)
Centerra Gold (CGAU)
Angi Com Cl A New (ANGI)
Tsakos Energy Navigation SHS (TEN)
I-80 Gold Corp (IAUX)
Navios Maritime Partners Com Unit Lpi (NMM)
Chimera Invt Corp Com Shs (CIM)
Praxis Precision Medicines I Com New (PRAX)
Ocular Therapeutix (OCUL)
Shutterstock (SSTK)

View all positions for Pale Fire Capital SE

Top funds holding Syros Pharmaceuticals

Bain Capital Life Sciences Investors
Siren
Samsara BioCapital
Point72 Asset Management
Flagship Ventures Management
Affinity Asset Advisors
Avidity Partners Management
Vanguard Group
Deep Track Capital
Opaleye Management
Blue Owl Capital Holdings
Kennedy Capital Management
ExodusPoint Capital Management
Exome Asset Management
Goldman Sachs Group

View all funds holding Syros Pharmaceuticals